Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Angiotensin-converting enzyme (ACE1, ACE2) gene variants are associated with COVID19 severity depending on the hypertension HP hypertension MESHD status.

    Authors: JUAN GOMEZ; GUILLERMO M ALBAICETA; MARTA GARCIA-CLEMENTE; CARLOS LOPEZ-LARREA; LAURA AMADO; TAMARA HERMIDA; ANA I ENRIQUEZ; PABLO HERRERO; SANTIAGO MELON; MARTA E ALVAREZ-ARGUELLES; SUSANA ROJO-ALBA; ALVARO LEAL-NEGREDO; REBECA LORCA; ELIAS CUESTA-LLAVONA; ELIECER COTO

    doi:10.1101/2020.06.11.20128033 Date: 2020-06-12 Source: medRxiv

    Background: The Angiotensin system is implicated in the pathogenesis of COVID19. First, ACE2 is the cellular receptor for SARS-COv-2, and expression of the ACE2 gene could regulate the individuals susceptibility to infection. In addition, the balance between ACE1 and ACE activity has been implicated in the pathogenesis of respiratory diseases MESHD and could play a role in the severity of COVID19. Functional ACE1 and ACE2 gene polymorphisms have been associated with the risk of cardiovascular and pulmonary diseases MESHD, and could thus also contribute to the outcome of COVID19. Methods: We studied 204 COVID19 patients (137 non-severe and 67 severe-ICU cases) and 536 age TRANS-matched controls. The ACE1 indel and ACE2 rs2285666 polymorphism were determined. Variables frequencies were compared between the groups by logistic regression. We also sequenced the ACE2 coding nucleotides in a group of patients. Results: Severe COVID19 was associated with hypertension HP hypertension MESHD male TRANS gender TRANS (p<0.001), hypertension HP hypertension MESHD (p=0.006), hypercholesterolaemia (p=0.046), and the ACE1-DD genotype (p=0.049). In the multiple logistic regression hypertension HP hypertension MESHD (p=0.02, OR=2.26, 95CI=1.12-4.63) and male TRANS gender TRANS (p=0.002; OR=3.15, 95CI=1.56-6.66) remained as independent significant predictors of severity. The ACE2 polymorphism was not associated with the disease outcome. The ACE2 sequencing showed no coding sequence variants that could explain an increased risk of developing COVID19. Conclusions: Adverse outcome of COVID19 was associated with male TRANS gender TRANS, hypertension HP hypertension MESHD, hypercholesterolemia HP hypercholesterolemia MESHD and the ACE1 genotype. The ACE1-indel was a significant risk factor for severe COVID19, but the effect was dependent on the hypertensive MESHD status.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.